health programs

Disruption of the medical industry has brought a plethora of rich benefits, from cures for diseases to new, AI-powered diagnostics methods to making healthcare more accessible for everyone, in every part of the world. With unparalleled access to hospitals, payers, care organisations, research institutions, and investors in the space Rockstart has built a launchpad for innovative health startups that are making a positive change in the industry.

Rockstart Health

Rockstart Health is a hands-on investment program focused on market-validated startups in the health sector. This is a first of its kind program wherein, our expert mentors don’t just offer advice but work within the startup teams in an operational capacity.

STATUS: Awaiting Launch


Dutch Digital Health Challenge

The only challenge in The Netherlands that gives startups the opportunity to showcase their solution at one of the main health conferences in Europe, and demonstrate how they innovate with partners.

STATUS: Program Complete



Cedexis Medical Eyewear

Graduated Rockstart Digital Health 2018


Cedexis Medical Eyewear develops, supplies and implements video glasses for the benefit of specialists and patients. Through the program Cedexis has scaled rapidly – the 2019 revenue expected to be EUR 1.5m on the run rate basis, an increase of approximately 4x from 2018.




Graduated Rockstart Digital Health 2018


Deepdee is diagnosing eye diseases by processing photos of the eye fundus with Artificial Intelligence/Machine Learning algorithms. Started in 2017, Deepdee has since demonstrated rapid progress. Since the conclusion of the program, Deepdee has secured EUR 300k in angel funding, started collaboration on age related macular degeneration with Radboud UMC and Erasmus UMC and won the Bayer Aspirin Social Innovation Award 2018.




Graduated Rockstart Digital Health 2015


MedAngel offers a unique and innovative solution that empowers individuals living with chronic conditions to eliminate the uncertainty about the storage and transport conditions of their medications. Founded in 2015 and winner of the 2017 Lyfebulb Novo Nordisk innovation award, MedAngel witnessed exponential growth within diabetes and rheumatoid arthritis patient populations, mainly fuelled by word-of-mouth promotion and organic growth. In 2018, MedAngel closed a Series A funding led by Holland Ventures and Oost NL.



see all alumni

health mentors

see all mentors

health partners

see all partners